Publications
94
Citations
2,328
Est. group size
~5
Recurring co-author estimate
Active years
29
Publishing since 1997
Wei Huang's research focuses on developing gene therapies, particularly using adeno-associated virus (AAV) vectors, to target fat tissue (adipose tissue) and the brain for treating metabolic and genetic disorders such as congenital leptin deficiency, Prader-Willi syndrome, and obesity-related complications. The work also spans animal model studies of metabolic disease, autism-related conditions, and some investigations into inflammatory diseases like rheumatoid arthritis and cancer-related pathways. Much of this research uses mouse models to test gene delivery methods and environmental interventions that affect metabolism and behavior.
Publication output has fluctuated over the past decade, dipping around 2021 before rising again, with a notable increase in 2024 and continued output in 2025.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Resveratrol in animal models of pancreatitis and pancreatic cancer: A systematic review with machine learning
Phytomedicine · 2025
- Targeting macrophage JAK3/STAT3 signaling with tectochrysin: a novel therapeutic strategy to ameliorate bone erosion and synovitis in rheumatoid arthritis
Journal of Orthopaedic Surgery and Research · 2025
- Dose-finding and in vivo safety study of an adipose targeted leptin gene therapy for congenital leptin deficiency
Molecular Therapy — Methods & Clinical Development · 2025
- Environmental Enrichment Normalizes Metabolic Function in the Murine Model of Prader–Willi Syndrome <i>Magel2</i>-Null Mice
Endocrinology · 2025
- Subcutaneous administration of adipose-tropic gene therapy for congenital leptin deficiency
Research Square · 2025
- Targeting Macrophage JAK3/STAT3 Signaling with Tectochrysin: A Novel Therapeutic Strategy to Ameliorate Bone Erosion and Synovitis in Rheumatoid Arthritis
Research Square · 2025
- Gene therapy approaches for obesity-induced adipose neuropathy: Device-targeted AAV-mediated neurotrophic factor delivery to adipocytes in subcutaneous adipose
Molecular Therapy · 2024
- Hypothalamic TrkB.FL overexpression improves metabolic outcomes in the BTBR mouse model of autism
PLoS ONE · 2023
- Environmental Enrichment Improves Motor Function and Muscle Transcriptome of Aged Mice
Advanced Biology · 2023
- Characterization of retinal degeneration phenotype in classic CLN2 disease using OCT biomarkers and an retinal model
Molecular Genetics and Metabolism · 2023
- AAV-Mediated Gene Delivery to Mouse Brown Adipose Tissue
Methods in molecular biology · 2023
- Age-associated B cells contribute to the pathogenesis of rheumatoid arthritis by inducing activation of fibroblast-like synoviocytes via TNF-α-mediated ERK1/2 and JAK-STAT1 pathways
Annals of the Rheumatic Diseases · 2022
- eNAMPT actions through nucleus accumbens NAD <sup>+</sup> /SIRT1 link increased adiposity with sociability deficits programmed by peripuberty stress
Science Advances · 2022
- Hypothalamic AAV-BDNF gene therapy improves metabolic function and behavior in the Magel2-null mouse model of Prader-Willi syndrome
Molecular Therapy — Methods & Clinical Development · 2022
- Targeting GABA signalling for cancer treatment
Nature Cell Biology · 2022
- Molecular Therapy — Methods & Clinical Development×6
- Molecular Therapy×4
- Cancer Research×2
- Brain Behavior and Immunity×2
- Aging×2
- Lei Cao
Medicine · The Ohio State University
- Yang Wang
Medicine · The Ohio State University
- Jiangjiang Zhu
Medicine · The Ohio State University
- Kristin I. Stanford
Medicine · The Ohio State University
- Kelsey M. Pinckard
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile